» Articles » PMID: 18182396

The Impact of LH-containing Gonadotropins on Diploidy Rates in Preimplantation Embryos: Long Protocol Stimulation

Overview
Journal Hum Reprod
Date 2008 Jan 10
PMID 18182396
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to evaluate the effect of ovarian stimulation with LH-containing gonadotropins (human menopausal gonadotropin, hMG), on ploidy of human cleavage-stage-embryos.

Methods: A total of 104 women, at ages 27-43 years, undergoing one cycle of controlled ovarian hyperstimulation for IVF in combination with preimplantation genetic diagnosis, were eligible for enrollment in this retrospective, controlled cohort study. Ovarian stimulation included down-regulation with long agonist and stimulation with either recombinant FSH or hMG. Since the ploidy of embryos changes with female age, patients were matched for age and dosage of the respective gonadotropin.

Results: Despite similar numbers of chromosomally normal embryos in both groups, women undergoing hMG stimulation demonstrated significantly higher percentages of diploid embryos than did the FSH-stimulated patients (69.8 versus 45.3%; P < 0.01).

Conclusions: Long protocol LH-containing ovarian stimulation improves embryonic ploidy in comparison to pure FSH stimulation. This observation may explain higher IVF pregnancy rates, reported for hMG stimulation in some studies.

Citing Articles

Association of ovarian stimulation and embryonic aneuploidy in in vitro fertilization cycles with preimplantation genetic testing: A narrative systematic review.

Rodriguez-Purata J, Gomez-Cuesta M, Cervantes-Bravo E JBRA Assist Reprod. 2021; 26(2):348-361.

PMID: 34751016 PMC: 9118955. DOI: 10.5935/1518-0557.20210069.


Trisomy 21 and Assisted Reproductive Technologies: A review.

Sanchez-Pavon E, Mendoza H, Garcia-Ferreyra J JBRA Assist Reprod. 2021; 26(1):129-141.

PMID: 34542250 PMC: 8769184. DOI: 10.5935/1518-0557.20210047.


A Comparison of Outcomes from Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist....

Bleau N, Agdi M, Son W, Tan S, Dahan M Int J Fertil Steril. 2017; 11(2):79-84.

PMID: 28670424 PMC: 5347454. DOI: 10.22074/ijfs.2017.4759.


Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols.

He B, Junping C, Li H, Weihong T, Lintao X, Shikai W Iran J Reprod Med. 2015; 13(6):337-44.

PMID: 26330847 PMC: 4555052.


The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin.

Arce J, Klein B, La Marca A Gynecol Endocrinol. 2014; 30(6):444-50.

PMID: 24576226 PMC: 4059219. DOI: 10.3109/09513590.2014.892066.